Answer
Yes, Singulair (montelukast) is indicated for prevention of asthma in which exercise-induced bronchoconstriction is the predominant component.
Sources for this answer
- Singulair Paediatric 5 mg Chewable TabletsOrganon Pharma (UK) Limited · emc · SmPC §4.1 Therapeutic Indications · Version 19Document updated
Sources checked